5:54 PM
 | 
Nov 08, 2013
 |  BC Extra  |  Company News

FDA approves Dainippon's Aptiom for seizures

FDA approved an NDA from the Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506) for Aptiom eslicarbazepine...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >